ReviewFoods (Basel, Switzerland)2026
Infrastructure for Sustainable Protein Innovation: A Global Value Chain Framework for CDMOs in Fermentation-Based Biomanufacturing.
Review in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Achieving more sustainable production in emerging biomanufacturing sectors depends not only on technological innovation but also on how production systems are organized, governed, and scaled. Fermentation-derived proteins produced through biomass and precision fermentation offer promising pathways to reduce the environmental impacts of conventional livestock production. However, their sustainability and circularity outcomes depend heavily on access to biomanufacturing infrastructure and coordination along global value chains. Drawing on Global Value Chain (GVC) theory and an integrative review of more than 40 academic and industry sources published between 2017 and 2026, spanning global value chain governance, biomanufacturing scale-up, CDMO functions, and sustainability and bioeconomy transitions, this study develops a conceptual framework that positions Contract Development and Manufacturing Organizations (CDMOs) as key infrastructural intermediaries in fermentation-based protein systems. CDMOs facilitate access to fermentation capacity, technical expertise, and regulatory capabilities, thereby shaping governance arrangements, capability development, and the scaling of innovation. In doing so, they influence how cleaner production principles, such as resource efficiency, circular feedstock integration, and improved environmental performance, are translated into industrial practice. The analysis also highlights risks linked to CDMO-driven scaling, including infrastructure concentration, dependency dynamics, and unequal access across regions. By integrating GVC perspectives with insights from sustainability transitions and the circular bioeconomy, the article advances understanding of how infrastructural intermediaries shape cleaner production outcomes in emerging biomanufacturing value chains.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.